Researchers developed a new test to detect invasive fungal infections caused by Aspergillus by targeting a molecule called galactosaminogalactan (GAG) on the fungus surface. The test worked very well in mice with the infection and showed better specificity than current methods. However, the test did not detect GAG in blood or other body fluids from human patients, suggesting that additional research is needed before it can be used clinically.